New Food Labels Target Sugar and Serving Size
(MedPage Today) — FDA plans to roll out new nutrition labels and this time the emphasis is not only on calories, but also on serving size and sugar. …read more
SLIT in Practice, Food Allergy Tx On the Way
SAN DIEGO (MedPage Today) — Food allergy oral immunotherapy and the approach of sublingual treatment for respiratory allergies into clinical practice will be in the spotlight at the American Academy…
Novel microfluidic system for high throughput droplet microfluidics launched by Dolomite
Dolomite, a world leader in the design & manufacture of microfluidic products, has launched Telos, an innovative system for high throughput droplet, particle, and flow product generation. It benefits a…
Morning Break: Sexual Healing and Killer Cannabis
(MedPage Today) — Health news and commentary from around the Web, gathered by the MedPage Today staff. …read more
CT Appears Safe in Patients With Pacemakers, ICDs
(MedPage Today) — Patients with cardiac rhythm management devices showed no clinically significant major or minor events related to computed tomography imaging over a 10-year period at two large-volume care…
Babies delivered by C-section may be more likely to become obese
Babies that are delivered by caeserean section are more likely to become overweight or obese as adults, according to researchers from Imperial College, London. …read more
Astellas' isavuconazole receives QIDP designation from FDA for zygomycosis treatment
Astellas Pharma Global Development, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc., announced today that the U.S. Food and Drug Administration designated isavuconazole as a Qualified Infectious Disease Product (QIDP)…
NxStage Medical revenue increases 7% to $69.4 million in fourth quarter 2013
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record financial results for the three and twelve months ended December 31, 2013, that include revenue slightly above…
Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013
Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today reported financial results for the three months and year ended December 31, 2013, and provided an update of recent corporate…
Covidien closes acquisition of Given Imaging
Covidien plc today announced that it has closed its acquisition of Given Imaging Ltd., providing the company additional scale and scope to serve a significant medical specialty, the multibillion dollar…